Join us on March 7 for our Educated Patient Summit on Breast Cancer taking place in Miami, FL! 

×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Events
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Sarcoma

Steve Rubin
It's pretty clear that I have a lot of work ahead of me after years of devastation from cancer, but lately, I'm taking a new approach.
Conor Killmurray
Patients with epithelioid sarcoma finally have a specific treatment after the FDA granted accelerated approval to Tazverik, providing new hope for the future of these patients.
Conor Killmurray
The Food and Drug Administration approved Tazverik for the treatment of patients with metastatic or locally advanced epithelioid sarcoma — marking the first treatment option specifically for these patients.
Steve Rubin
Having loved ones by your side is right up there in importance with any aspect of healing from cancer.
Steve Rubin
Thoughts on New Year's resolutions and planning for the years ahead when your future is tied up in uncertainty because of cancer. 
Katie Kosko
From a newly proposed rule to help lower prescription drug prices to an oncology nurse and a patient with cancer singing “O Holy Night,” here’s what is making headlines in the cancer space this week.
Kristie L. Kahl
Now a 10-year survivor of bone cancer, Dana Vaughns chose to triumph over his disease and joined Bristol-Myers Squibb on its Coast 2 Coast 4 Cancer ride.
Kristie L. Kahl
Dana Vaughns and his colleagues rode 3,000 miles across the U.S. in support of funding research for the V Foundation.
Debu Tripathy, M.D.
Where does hope lie when it comes to improving the treatment landscape for rare cancers?
Arlene Weintraub
A new drug can break the circuit of cancer-causing effects that develop when certain genes fuse.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×